Omega-3 fatty acid deficiency augments amphetamine-induced behavioral sensitization in adult DBA/2J mice: Relationship with ventral striatum dopamine concentrations

Synapse

Volumn 62, Issue 10, 2008, Pages 725-735

  Mcnamara, Robert K ^a   Sullivan, Juliana ^a   Richtand, Neil M ^a,b   Jandacek, Ronald ^a   Rider, Therese ^a   Tso, Patrick ^a   Campbell, Nick ^a   Lipton, Jack ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Amphetamine; Arachidonic acid; DBA 2J mice; Docosahexaenoic acid; Dopamine; Noradrenaline; Nucleus accumbens; Prefrontal cortex; Sensitization; Serotonin

Indexed keywords

AMPHETAMINE; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; DOPAMINE; MONOAMINE; NORADRENALIN; OMEGA 3 FATTY ACID; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; DIET; DOPAMINERGIC SYSTEM; ESSENTIAL FATTY ACID DEFICIENCY; LOCOMOTION; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; SENSITIZATION;

AGE FACTORS; AMPHETAMINE; ANIMALS; BASAL GANGLIA; DOPAMINE; FATTY ACIDS, OMEGA-3; MALE; MICE; MICE, INBRED DBA; MOTOR ACTIVITY;

EID: 50249182341     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20542     Document Type: Article

References (56)

1. Abi-Dargham A, Gil R, Krystal J, Baldwin RM, Seibyl JP, Bowers M, van Dyck CH, Charney DS, Innis RB, Laruelle M. 1998. Increased striatal dopamine transmission in schizophrenia: Confirmation in a second cohort. Am J Psychiatry 155:761-767.
2. Bell DS. 1973. The experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry 29:35-40.
3. Bhattacharjee AK, Chang L, White L, Bazinet RP, Rapoport SI. 2006. D-Amphetamine stimulates D2 dopamine receptor-mediated brain signaling involving arachidonic acid in unanesthetized rats. J Cereb Blood Flow Metab 26:1378-1388.
4. Brady KT, Lydiard RB, Malcolm R, Ballenger JC. 1991. Cocaine-induced psychosis. J Clin Psychiatry 52:509-512.
5. Cabib S. 1993. Strain-dependent behavioural sensitization to amphetamine: Role of environmental influences. Behav Pharmacol 4:367-374.
6. Cass WA, Larson G, Fitzpatrick FA, Zahniser NR. 1991. Inhibitors of arachidonic acid metabolism: Effects on rat striatal dopamine release and uptake. J Pharmacol Exp Ther 257:990-996.
7. Chalon S. 2006. ω-3 Fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids 75:259-269.
8. Chang MC, Jones CR. 1998. Chronic lithium treatment decreases brain phospholipase A2 activity. Neurochem Res 23:887-892.
9. Chen N, Appell M, Berfield JL, Reith ME. 2003. Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporter. Eur J Pharmacol 478:89-95.
10. Delion S, Chalon S, Guilloteau D, Besnard JC, Durand G. 1996. α-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. J Neurochem 66:1582-1591.
11. Di Marzo V, Vial D, Sokoloff P, Schwartz JC, Piomelli D. 1993. Selection of alternative G-mediated signaling pathways at the dopamine D2 receptor by protein kinase C. J Neurosci 13:4846-4853.
12. Giambalvo CT. 1988. Protein kinase C and dopamine release. II. Effect of dopamine acting drugs in vivo. Biochem Pharmacol 37:4009-4017.
13. Gnegy ME, Hong P, Ferrell ST. 1993. Phosphorylation of neuromodulin in rat striatum after acute and repeated, intermittent amphetamine. Mol Brain Res 20:289-298.
14. Imperato A, Obinu MC, Carta G, Mascia MS, Casu MA, Gessa GL. 1996. Reduction of dopamine release and synthesis by repeated amphetamine treatment: Role in behavioral sensitization. Eur J Pharmacol 317:231-237.
15. Iwata S, Hewlett GH, Ferrell ST, Czernik AJ, Meiri KF, Gnegy ME. 1996. Increased in vivo phosphorylation state of neuromodulin and synapsin I in striatum from rats treated with repeated amphetamine. J Pharmacol Exp Ther 278:1428-1434.
16. Johnson LA, Guptaroy B, Lund D, Shamban S, Gnegy ME. 2005. Regulation of amphetamine-stimulated dopamine efflux by protein kinase Cβ. J Biol Chem 280:10914-10919.
17. Jones CR, Arai T, Bell JM, Rapoport SI. 1996. Preferential in vivo incorporation of [3H]arachidonic acid from blood in rat brain synaptosomal fractions before and after cholinergic stimulation. J Neurochem 67:822-829.
18. Keck PE Jr, McElroy SL, Havens JR, Altshuler LL, Nolen WA, Frye MA, Suppes T, Denicoff KD, Kupka R, Leverich GS, Rush AJ, Post RM. 2003. Psychosis in bipolar disorder: Phenomenology and impact on morbidity and course of illness. Compr Psychiatry 44:263-269.
19. Kodas E, Page G, Zimmer L, Vancassel S, Guilloteau D, Durand G, Chalon S. 2002a. Neither the density nor function of striatal dopamine transporters were influenced by chronic n-3 polyunsaturated fatty acid deficiency in rodents. Neurosci Lett 321:95-99.
20. Kodas E, Vancassel S, Lejeune B, Guilloteau D, Chalon S. 2002b. Reversibility of n-3 fatty acid deficiency-induced changes in dopaminergic neurotransmission in rats: Critical role of developmental stage. J Lipid Res 43:1209-1219.
21. Laruelle M. 2000. The role of endogenous sensitization in the pathophysiology of schizophrenia: Implications from recent brain imaging studies. Brain Res Rev 31:371-384.
22. Lee CH, Hajra AK. 1991. Molecular species of diacylglycerols and phosphoglycerides and the postmortem changes in the molecular species of diacylglycerols in rat brains. J Neurochem 56:370-379.
23. Levant B, Radel JD, Carlson SE. 2004. Decreased brain docosahexaenoic acid during development alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation. Behav Brain Res 152:49-57.
24. L'hirondel M, Cheramy A, Godeheu G, Glowinski J. 1995. Effects of arachidonic acid on dopamine synthesis, spontaneous release, and uptake in striatal synaptosomes from the rat. J Neurochem 64:1406-1409.
25. Loder MK, Melikian HE. 2003. The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines. J Biol Chem 278:22168-22174.
26. McNamara RK, Carlson SE. 2006. Role of ω-3 fatty acids in brain development and function: Potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot Essent Fatty Acids 74:329-349.
27. McNamara RK, Ostrander M, Abplanalp W, Richtand NM, Benoit S, Clegg D. 2006a. Modulation of phosphoinositide-protein kinase C signal transduction by ω-3 fatty acids: Implications for the pathophysiology and treatment of recurrent neuropsychiatrie illness. Prostaglandins Leukot Essent Fatty Acids 74:237-257.
28. 2A receptor binding in the adult rat prefrontal cortex. Biol Psychiatry 59:S146.
29. McNamara RK, Jandacek R, Rider T, Tso P, Richtand NM, Stanford K. 2007. Abnormalities in the fatty acid composition of the post-mortem orbitofrontal cortex of schizophrenic patients: Gender differences and partial normalization with antipsychotic medications. Schizophr Res 91:37-50.
30. McNamara RK, Able J, Jandacek R, Roder T, Tso P. 2008a. Constitutive elevations in the arachidonic acid:docosahexanoic acid ratio in brains of sensitization-prone C57BL/6J mice relative to sensitization-resistant inbred DBA/2J mice. Soc Biol Psychiatry 63.
31. McNamara RK, Sullivan J, Richtand NM. 2008b. ω-3 Fatty acid deficiency augments the development of behavioral sensitization in adult mice: Prevention by chronic lithium treatment. J Psychiatric Res 42:458-468.
32. McNamara RK, Jandacek R, Rider T, Tso P, Stanford K, Hahn C-G, Richtand NM. Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder. Psychiatric Res (in press).
33. Miranda M, Dionne KR, Sorkina T, Sorkin A. 2007. Three ubiquitin conjugation sites in the amino terminus of the dopamine transporter mediate protein kinase C-dependent endocytosis of the transporter. Mol Biol Cell 18:313-323.
34. Mirnikjoo B, Brown SE, Kim HF, Marangell LB, Sweatt JD, Weeber EJ. 2001. Protein kinase inhibition by ω-3 fatty acids. J Biol Chem 276:10888-10896.
35. Mitchell J, Vierkant AD. 1991. Delusions and hallucinations of cocaine abusers and paranoid schizophrenics: A comparative study. J Psychol 125:301-310.
36. Namkung Y, Sibley DR. 2004. Protein kinase C mediates phosphorylation, desensitization, and trafficking of the D2 dopamine receptor. J Biol Chem 279:49533-49541.
37. Niculescu M, Ehrlich ME, Unterwald EM. 2005. Age-specific behavioral responses to psychostimulants in mice. Pharmacol Biochem Behav 82:280-288.
38. Orsini C, Buchini F, Piazza PV, Puglisi-Allegra S, Cabib S. 2004. Susceptibility to amphetamine-induced place preference is predicted by locomotor response to novelty and amphetamine in the mouse. Psychopharmacology (Berl) 172:264-270.
39. Orsini C, Bonito-Oliva A, Conversi D, Cabib S. 2005. Susceptibility to conditioned place preference induced by addictive drugs in mice of the C57BL/6 and DBA/2 inbred strains. Psychopharmacology (Berl) 181:327-336.
40. Perez SE, Lazarov O, Koprich JB, Chen EY, Rodriguez-Menendez V, Lipton JW, Sisodia SS, Mufson EJ. 2005. Nigrostriatal dysfunction in familial Alzheimer's disease-linked APPswe/PS1DeltaE9 transgenic mice. J Neurosci 25:10220-10229.
41. Phillips TJ, Dickinson S, Burkhart-Kasch S. 1994. Behavioral sensitization to drug stimulant effects in C57BL/6J and DBA/2J inbred mice. Behav Neurosci 108:789-803.
42. Porrino LJ, Lucignani G, Dow-Edwards D, Sokoloff L. 1984. Correlation of dose-dependent effects of acute amphetamine administration on behavior and local cerebral metabolism in rats. Brain Res 307:311-320.
43. Reid MS, Hsu K, Tolliver BK, Crawford CA, Berger SP. 1996. Evidence for the involvement of phospholipase A2 mechanisms in the development of stimulant sensitization. J Pharmacol Exp Ther 276:1244-1256.
44. Robinson TE, Jurson PA, Bennett JA, Bentgen KM. 1988. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: A microdialysis study in freely moving rats. Brain Res 462:211-222.
45. Segal DS, Kuczenski R. 1992. In vivo microdialysis reveals a diminished amphetamine-induced DA response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment. Brain Res 571:330-337.
46. Seung Kim HF, Weeber EJ, Sweatt JD, Stoll AL, Marangell LB. 2001. Inhibitory effects of ω-3 fatty acids on protein kinase C activity in vitro. Mol Psychiatry 6:246-248.
47. Shoji-Kasai Y, Itakura M, Kataoka M, Yamamori S, Takahashi M. 2002. Protein kinase C-mediated translocation of secretory vesicles to plasma membrane and enhancement of neurotransmitter release from PC12 cells. Eur J Neurosci 15:1390-1394.
48. 2+. Br J Pharmacol 139:1014-1022.
49. Suzuki H, Manabe S, Wada O, Crawford MA. 1997. Rapid incorporation of docosahexaenoic acid from dietary sources into brain microsomal, synaptosomal and mitochondrial membranes in adult mice. Int J Vitam Nutr Res 67:272-278.
50. Ventura R, Alcaro A, Cabib S, Conversi D, Mandolesi L, Puglisi-Allegra S. 2004. Dopamine in the medial prefrontal cortex controls genotype-dependent effects of amphetamine on mesoaccumbens dopamine release and locomotion. Neuropsychopharmacology 29:72-80.
51. Vezina P. 2004. Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs. Neurosci Biobehav Rev 27:827-839.
52. Zhang L, Reith ME. 1996. Regulation of the functional activity of the human dopamine transporter by the arachidonic acid pathway. Eur J Pharmacol 315:345-354.
53. Zimmer L, Breton P, Durand G, Guilloteau D, Besnard J-C, Chalon S. 1999. Prominent role of n-3 polyunsaturated fatty acids in cortical dopamine metabolism. Nutr Neurosci 2:257-265.
54. Zimmer L, Delpal S, Guilloteau D, Aïoun J, Durand G, Chalon S. 2000a. Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex. Neurosci Lett 284:25-28.
55. Zimmer L, Delion-Vancassel S, Durand G, Guilloteau D, Bodard S, Besnard JC, Chalon S. 2000b. Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids. J Lipid Res 41:32-40.
56. Zimmer L, Vancassel S, Cantagrel S, Breton P, Delamanche S, Guilloteau D, Durand G, Chalon S. 2002. The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids. Am J Clin Nutr 75:662-667.